Future therapy for hepatitis B virus infection
書誌事項
- 公開日
- 2015-08
- 資源種別
- journal article
- 権利情報
-
- http://www.springer.com/tdm
- DOI
-
- 10.1007/s12328-015-0590-y
- 公開者
- Springer Science and Business Media LLC
この論文をさがす
説明
We can now control hepatitis B virus infection by continuously administering nucleoside and nucleotide analogues such as entecavir and tenofovir. These drugs are generally safe and sufficiently effective, but future drugs are needed that can show off-treatment efficacy--in other words, eradication of latent hepatitis B virus DNA (covalently closed circular DNA) in the hepatocytes. This article is an overview of new drugs under development and some novel strategies to inhibit hepatitis B virus proliferation.
収録刊行物
-
- Clinical Journal of Gastroenterology
-
Clinical Journal of Gastroenterology 8 (4), 167-171, 2015-08
Springer Science and Business Media LLC
